Novo Nordisk, the Danish maker of Ozempic and Wegovy, announced Tuesday that it has asked the Food and Drug Administration to ...

Nearly two years after reporting successful results from a phase 3 trial of its oral version of injected obesity treatment ...

It's little secret that America has a weight problem. For decades, Americans have embraced and abandoned countless ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Representatives from Lilly said the company plans to seek FDA approval to market the drug for weight loss this year and diabetes in 2026. The FDA’s review could take months, yet analysts ...

But this one, for Lilly’s first diabetes and weight-loss pill based on the GLP-1 hormone, was particularly fraught. Days ...

New Delhi: Taking tirzepatide drug once a week may produce clinically meaningful and sustained weight loss ... was approved in November 2023 by the US Food and Drug Administration (FDA) (Zepbound ...

Get weight loss medications through licensed medical providers to ensure you get FDA-approved, properly dosed ... might not provide the correct dosage or could include harmful impurities in ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...